Excellent Conference Presentation, Second Prize (2017): Construction and Anti-Tumor Effect of CD22-Platelet-DOX Targeted Drug Delivery System
Best Paper Award (2019): National Thrombosis and Hemostasis Academic Conference
First Prize (2017): Research on Platelet-Loaded Chemotherapy Drugs for the Treatment of Malignant Tumors, Jiangsu Oncology Medical Science and Technology Award
First Prize (2019): Application of Immune Recognition-Based Targeted Platelet Drug Delivery System in Hematological Tumors, Provincial and Ministerial Best Paper Award
First Prize (2020): Construction and Implementation of Personalized Diagnosis and Treatment Strategy System for Malignant Hematological Diseases Based on Artificial Intelligence, Provincial and Ministerial Medical New Technology Introduction Award
Third Prize (2017): Basic and Clinical Translational Research on Cardiac Steroids and Nanotechnology for the Treatment of Lymphatic System Tumors, Nanjing Science and Technology Progress Award
Research
Development and translation of diagnostic and therapeutic technologies for live cells such as platelets and stem cells Mechanisms and interventions for the recurrence of malignant hematological diseases New methods for personalized diagnosis and treatment of hematological diseases based on artificial intelligence
Overcoming Hypoxia by Multistage Nano Delivery System to Inhibit Mitochondrial Respiration for Photodynamic Therapy, Peipei Xu, 2019
Tailoring the component of protein corona via simple chemistry, Peipei Xu, 2019
Licochalcone A suppresses Sp1 expression with potential anti-myeloma activity, Peipei Xu, 2021
Doxorubicin-loaded platelets as a smart drug delivery system: An improved therapy for lymphoma, Peipei Xu, 2017
Ultrafast glucose-responsive, high loading capacity erythrocyte to self-regulate the release of insulin, Peipei Xu, 2018
Platinum prodrug inhibiting tumor recurrence and metastasis by concurrent chemo radiotherapy, Peipei Xu, 2022
Anti-Fas Antibody Conjugated Nanoparticles Enhancing the Antitumor Effect of Camptothecin by Activating the Fas−FasL Apoptotic Pathway, Peipei Xu, 2016
Screening T‑Cell Activity via a Photodetachable DNA-Copolymer Nanocage and Its Therapeutic Application, Peipei Xu, 2022
Overcoming the blood-brain barrier by using a multistage platelet delivery system to inhibit central nervous system lymphoma, Peipei Xu, 2022
Ultrafast glucose-responsive, high loading capacity erythrocyte to self-regulate the release of insulin, Peipei Xu, 2018
PRMT5 regulates cell pyroptosis by silencing CASP1 in multiple myeloma, Peipei Xu, 2021
Novel two-chain structure utilizing KIRS2/DAP12 domain improves the safety and efficacy of CAR-T cells in adults with r/r B-ALL, Peipei Xu, 2021
Vincristine-Loaded Platelets Coated with Anti-CD41 MAbs: A New Proposal for the Treatment of Immune Thrombocytopenia, Peipei Xu, 2019
Nitroxide-radicals-modified gold nanorods for in vivo CT/MRI-guided photothermal cancer therapy, Peipei Xu, 2018
Daunorubicin-Loaded CdTe QDs Conjugated with Anti-CD123 mAbs: A Novel Delivery System for Myelodysplastic Syndromes Treatment, Peipei Xu, 2020
Gene signatures and prognostic values of m6A-related genes in multiple myeloma, Peipei Xu, 2021
Identification of three immune molecular subtypes associated with immune profiles, immune checkpoints, and clinical outcome in multiple myeloma, Peipei Xu, 2021
Doxorubicin-loaded platelets as a smart drug delivery system: An improved therapy for lymphoma, Peipei Xu, 2017
Characteristics and mutation analysis of Ph-positive leukemia patients with T315I mutation receiving tyrosine kinase inhibitors, Peipei Xu, 2017
A centromere-associated gene score for rapid determination of risk in multiple myeloma, Peipei Xu, 2020
Bortezomib activation of mTORC1 pathway mediated by NOX2-drived reactive oxygen species results in apoptosis in primary dorsal root ganglion neurons, Peipei Xu, 2021
Pre-treatment red blood cell distribution width provides prognostic information in multiple myeloma, Peipei Xu, 2018
PLP2 Expression as a Prognostic and Therapeutic Indicator in High-Risk Multiple Myeloma, Peipei Xu, 2020
Expression of MAGE-C1/CT7 provides prognostic information in multiple myeloma, Peipei Xu, 2017
MiR-181a enhances drug sensitivity of mixed lineage leukemia- rearranged acute myeloid leukemia by increasing poly(ADP-ribose) polymerase1 acetylation, Peipei Xu, 2021
Effects of digoxin on cell cycle, apoptosis and NF-kappa B pathway in Burkitt's lymphoma cells and animal model, Peipei Xu, 2017
TP53 mutation predicts the poor prognosis of non-Hodgkin lymphomas: Evidence from a meta-analysis, Peipei Xu, 2017
Anti-CD22-conjugated CdTe QDs co-loaded with doxorubicin and gambogic acid: a novel platform for lymphoma treatment, Peipei Xu, 2017
Correlation of miR- 181a and three HOXA genes as useful biomarkers in acute myeloid leukemia, Peipei Xu, 2020
Wogonin Inhibits Growth of Mantle Cell Lymphoma Cells, through Nuclear Factor-κB Signaling Pathway, Peipei Xu, 2018
Development of follicular lymphoma after treatment of diffuse large B- cell lymphoma: two case reports with review of literature, Peipei Xu, 2018
Successful management of a complicated clinical crisis: A patient with left- sided endocarditis and secondary hemophagocytic lymphohistiocytosis: a rare case report and literature review, Peipei Xu, 2017
Doxorubicin-Loaded CuS Nanoparticles Conjugated with GFLG: A Novel Drug Delivery System for Lymphoma Treatment, Peipei Xu, 2019
Higher single dose of bortezomib plus thalidomide and dexamethasone is a promising therapy for newly diagnosed multiple myeloma, Peipei Xu, 2019
Refractory multiple myeloma with extramedullary plasmacytoma of the spleen and suspicious teratoma: a rare case report and literature review, Peipei Xu, 2021
